How many institutions own INM stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own INM shares is 14, representing 70.69% of the company's common stock.

Who are the major shareholders selling InMed Pharmaceuticals Inc. stock?

CITADEL ADVISORS LLC, in the last quarter, reduced its stake in INM by -100% restricting it's holding to 0 shares of worth nearly -. BAADER BANK AKTIENGESELLSCHAFT also lessened -100% of the INM shares from its portfolio, reducing its holding to 0 shares of worth -. BANK OF AMERICA CORP /DE/ also shunned INM shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying INM stock?

As per its latest 13F filing, TWO SIGMA SECURITIES, LLC increased its stake in INM by 19.61% in the last quarter. The institutional holder raised its holding to 15.42 thousand shares having worth more than $5.61K. BFSG, LLC also added 100% more shares of INM to its portfolio, raising its holding to 200 shares of worth $73.00. ADVISORNET FINANCIAL, INC also increased its INM shares holding by 100% which brought its holding to 80 shares worth $29.00.

INM's major insiders: who are they?

The insider with the most stakes in INM is ADAR1 Capital Management, LLC , 10 percent owner at the company. Additionally, INM stock is highly held by SVP, GM of BayMedica LLC Johnson Shane Aaron and 10 percent owner Vivo Opportunity, LLC among others.

Did an insider recently sell INM stock?

Company executives, directors, and other insiders own 0.12% percent of InMed Pharmaceuticals Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which INM insiders have sold stock, totaling 0 shares. Insiders that have sold shares include MANCINI ALEXANDRA DIANE JANET.

Which insider recently purchased INM stock?

There have been 17 transaction(s) during the past 6-months in which InMed Pharmaceuticals Inc. insiders have bought stock, totalling 94891 shares

How much of INM does insiders own?

Around 2.21M InMed Pharmaceuticals Inc. shares are held by insiders, which represents about 0.12% of INM stock.

Who is the insider with the largest stake?

INM 10 percent owner, ADAR1 Capital Management, LLC holds the largest portfolio of the company's shares. INM shares owned by ADAR1 total nearly 801 thousand.

Which institution holds the most shares in INM?

CITADEL ADVISORS LLC is the largest institutional owner in INM which holds 0 shares worth - or 0% of the total INM shares outstanding followed by BAADER BANK AKTIENGESELLSCHAFT with ownership of 0 shares representing 0% of the INM ownership. BANK OF AMERICA CORP /DE/ is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is InMed Pharmaceuticals Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the INM is concerned, it is a stock which is not optionable.

Is there a short position on INM's shares?

Number of INM shares short is 82.73K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding INM shares are there?

As of today, 2.00M shares of INM are outstanding.

Is there many float in INM stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, INM has 1.12M shares in float.

INM short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for INM is 0.55.

InMed Pharmaceuticals (INM) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares4.13

Short Percent Of Float4.14

Shares Outstanding2.00M

Shares Float1.12M

Shares Short82.73K

Short Ratio0.55

4.14%

Short % of Float

4.13%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.12% Percentage of Shares held by All Insiders

70.69% Percentage of Shares held by All Institutions

70.78% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 70.69% of INM shares are held by financial institutions. CITADEL ADVISORS LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in InMed Pharmaceuticals Inc. is owned by the company. BAADER BANK AKTIENGESELLSCHAFT owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2024	CITADEL ADVISORS LLC	0%	0	-	-56.67K	-100.00%
Dec 31, 2024	BAADER BANK AKTIENGESELLSCHAFT	0%	0	-	-22.61K	-100.00%
Dec 31, 2024	BANK OF AMERICA CORP /DE/	0%	0	-	-100	-100.00%
Dec 31, 2024	GLOBAL RETIREMENT PARTNERS, LLC	0%	0	-	-6	-100.00%
Dec 31, 2024	ADVISORSHARES INVESTMENTS LLC	0%	0	-	-733.3K	-100.00%
Dec 31, 2024	UBS GROUP AG	0%	0	-	-212.04K	-100.00%
Dec 31, 2024	ALLSQUARE WEALTH MANAGEMENT LLC	0%	0	-	-21	-100.00%
Dec 31, 2024	VIRTU FINANCIAL LLC	0%	0	-	-28.42K	-100.00%
Dec 31, 2024	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-50.3K	-100.00%
Dec 31, 2024	ADVISOR GROUP HOLDINGS, INC.	0%	27	5	0	0
Dec 31, 2024	FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0%	0	-	-19	-100.00%
Dec 31, 2024	HRT FINANCIAL LP	0%	0	-	-38.37K	-100.00%
Mar 31, 2024	NATIONAL BANK OF CANADA /FI/	0%	12	3	0	0
Mar 31, 2024	TWO SIGMA SECURITIES, LLC	0.19%	15.42K	5.61K	2.53K	+19.61%
Mar 31, 2024	CITADEL ADVISORS LLC	0.16%	12.73K	4.48K	-21.28K	-62.58%
Mar 31, 2024	BFSG, LLC	0%	200	73	200	+100.00%
Mar 31, 2024	QUBE RESEARCH & TECHNOLOGIES LTD	0%	200	70	0	0
Mar 31, 2024	BANK OF AMERICA CORP /DE/	0%	100	36	0	0
Mar 31, 2024	ADVISORNET FINANCIAL, INC	0%	80	29	80	+100.00%
Mar 31, 2024	UBS GROUP AG	0%	41	15	41	+100.00%
Mar 31, 2024	ADVISOR GROUP HOLDINGS, INC.	0%	41	13	0	0
Mar 31, 2024	ALLSQUARE WEALTH MANAGEMENT LLC	0%	21	8	0	0
Mar 31, 2024	FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0%	19	7	19	+100.00%
Mar 31, 2024	GLOBAL RETIREMENT PARTNERS, LLC	0%	6	2	0	0
Mar 31, 2024	TORONTO DOMINION BANK	0%	2	1	0	0
Mar 31, 2024	ADVISORY SERVICES NETWORK, LLC	0%	0	-	-59	-100.00%
Mar 31, 2024	TD WATERHOUSE CANADA INC.	0%	0	-	-85	-100.00%
Mar 31, 2024	ARMISTICE CAPITAL, LLC	3.35%	266.97K	97.18K	61K	+29.62%
Mar 31, 2024		0%	19	7	19	+100.00%
Mar 31, 2024	SABBY MANAGEMENT, LLC	4.54%	361.73K	131.67K	-150.21K	-29.34%
Mar 31, 2024	RENAISSANCE TECHNOLOGIES LLC	0.35%	28.3K	10K	-10.6K	-27.25%
Dec 31, 2023	TORONTO DOMINION BANK	0%	2	1	0	0
Dec 31, 2023	UBS GROUP AG	0%	0	-	-69	-100.00%
Dec 31, 2023	GABLES CAPITAL MANAGEMENT INC.	0%	0	-	-1	-100.00%
Dec 31, 2023	BANK OF AMERICA CORP /DE/	0%	100	42	100	+100.00%
Dec 31, 2023	QUBE RESEARCH & TECHNOLOGIES LTD	0%	200	83	200	+100.00%
Dec 31, 2023	TWO SIGMA SECURITIES, LLC	0.16%	12.89K	5.36K	12.89K	+100.00%
Dec 31, 2023	CITADEL ADVISORS LLC	0.43%	34.01K	14.15K	34.01K	+100.00%
Dec 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0.49%	38.9K	16K	38.9K	+100.00%
Dec 31, 2023	ARMISTICE CAPITAL, LLC	2.58%	205.97K	85.68K	205.97K	+100.00%
Dec 31, 2023	GLOBAL RETIREMENT PARTNERS, LLC	0%	6	2	6	+100.00%
Dec 31, 2023	NATIONAL BANK OF CANADA /FI/	0%	12	5	-8	-40.00%
Dec 31, 2023	ALLSQUARE WEALTH MANAGEMENT LLC	0%	21	9	0	0
Dec 31, 2023	ADVISOR GROUP HOLDINGS, INC.	0%	41	15	-20	-32.79%
Dec 31, 2023	ADVISORY SERVICES NETWORK, LLC	0%	59	25	59	+100.00%
Dec 31, 2023		0%	85	43	0	0
Dec 31, 2023	SABBY MANAGEMENT, LLC	6.42%	511.93K	212.97K	511.93K	+100.00%

Insiders

Among the INM insiders holding of 0.12% of the stake in company, ADAR1 CAPITAL MANAGEMENT, LLC, 10 percent owner, holds the largest shares of 801K. JOHNSON SHANE AARON, SVP, GM of BayMedica LLC, is the second largest INM insider with ownership of 304.6K shares. VIVO OPPORTUNITY, LLC, 10 percent owner, stands third with possession of 75.02K shares of that stake.

Insiders	Designation	Shares Held
ADAR1 CAPITAL MANAGEMENT, LLC	10 percent owner	801K
JOHNSON SHANE AARON	SVP, GM of BayMedica LLC	304.6K
VIVO OPPORTUNITY, LLC	10 percent owner	75.02K
ADAMS ERIC A	President & CEO	43.96K
HULL ANDREW	director	38.26K
COLWILL BRUCE	CFO	11.52K
MANCINI ALEXANDRA DIANE JANET	Consultant	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jul 16, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.55	2	3.1	75.02K
Jul 15, 2026	ADAR1 CAPITAL MANAGEMENT, LLC	PURCHASE	1.55	1K	1.56K	801K
Jul 15, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.55	1.39K	2.15K	75.02K
Jul 14, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.55	493	764.15	73.63K
Jul 02, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.55	147	227.85	73.14K
Jul 01, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.55	398	616.9	72.99K
Jun 30, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.54	55	84.7	72.59K
Jun 08, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.52	2.98K	4.53K	72.54K
Jun 05, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.57	5.05K	7.92K	69.55K
Jun 04, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.57	618	970.26	64.51K
Jun 03, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.55	714	1.11K	63.89K
Jun 02, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.52	2.1K	3.18K	63.18K
Jun 01, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.55	1.5K	2.32K	61.08K
May 29, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.57	1.63K	2.56K	59.58K
May 21, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.69	3.12K	5.27K	57.95K
May 20, 2026	VIVO OPPORTUNITY, LLC	PURCHASE	1.56	5.15K	8.04K	54.83K
May 19, 2026	ADAR1 CAPITAL MANAGEMENT, LLC	PURCHASE	1.60	68.55K	109.67K	400K
Jul 31, 2024	MANCINI ALEXANDRA DIANE JANET	SALE	0.18	240	42.31	0
Feb 21, 2024	HULL ANDREW	PURCHASE	0.39	37.5K	14.63K	38.26K
Feb 20, 2024	ADAMS ERIC A	PURCHASE	0.36	41.6K	14.92K	43.96K
Apr 14, 2022	ADAMS ERIC A	PURCHASE	0.89	14.16K	12.66K	59K
Apr 13, 2022	ADAMS ERIC A	PURCHASE	0.85	8.56K	7.28K	44.84K
Jan 24, 2022	COLWILL BRUCE	PURCHASE	1.09	5K	5.44K	11.52K
Jan 06, 2022	JOHNSON SHANE AARON	PURCHASE	1.26	8.5K	10.71K	304.6K
Dec 30, 2021	JOHNSON SHANE AARON	PURCHASE	1.33	8.09K	10.74K	296.1K
Nov 15, 2021	JOHNSON SHANE AARON	PURCHASE	1.37	5K	6.85K	288K
Sep 29, 2021	ADAMS ERIC A	PURCHASE	1.73	8.8K	15.22K	36.28K
Sep 28, 2021	ADAMS ERIC A	PURCHASE	1.75	11.4K	19.98K	27.48K
Sep 28, 2021	COLWILL BRUCE	PURCHASE	1.77	5K	8.84K	6.52K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE94.89K17

SALES00

NET SHARES94.89K17

SHARES HELD2.21M17

% NET SHARES-95.71%0%

INM Stock Ownership Breakdown